# China Pharma Holdings, Inc.: Form 8-K, filed Feb 24, 2023

- Company: [China Pharma Holdings, Inc.](/companies/cphi.md) (CIK 1106644)
- Form: 8-K
- Filed: 2023-02-24
- Accepted by EDGAR: Feb 24, 2023, 16:05 ET
- Period: 2023-02-24
- Accession: 0001213900-23-014316
- Inline XBRL: yes
- Main document: https://www.sec.gov/Archives/edgar/data/1106644/000121390023014316/ea174228-8k_chinapharma.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/1106644/000121390023014316/

## Items reported

- Item 7.01: Regulation FD disclosure
- Item 9.01: Financial statements and exhibits

## Sections

Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. https://www.sec.gov/Archives/edgar/data/1106644/000121390023014316/ea174228-8k_chinapharma.htm

Filed Feb 24, 2023.
Source: SEC EDGAR, the filing index for accession 0001213900-23-014316. Last ingested by Listed: Oct 30, 2026, 16:51 ET. No prices; not investment advice.